Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

52,657

143

150

Adheron Therapeutics

Adheron is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases.

Acquired by Roche on October 07, 2015

Founded: January 01, 2003

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
Turn Biotechnologies	Pharmaceuticals & Biotechnology	Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...
NeuroX1	Pharmaceuticals & Biotechnology	The new standard in computational neuroscience - NeuroX1 is a computational drug design company bui ...

View more competitors»

Date	Round	Amount	Investors
Jul 31, 2015	Convertible Note	$ 1,500,000

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
There are no team members.